Cefepime

Cefepime
Cefepime
Systematic (IUPAC) name
(6R,7R,Z)-
7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-
3-((1-methylpyrrolidinium-1-yl)methyl)-8-oxo-5-thia-
1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate
Clinical data
Trade names Maxipime
AHFS/Drugs.com monograph
MedlinePlus a698021
Pregnancy cat. B1 (Au)
Legal status S4 (Au)
Routes Intravenous, intramuscular
Pharmacokinetic data
Bioavailability 100% (IM)
Metabolism Hepatic 15%
Half-life 2 hours
Excretion Renal 70–99%
Identifiers
CAS number 88040-23-7 YesY
ATC code J01DE01
PubChem CID 5479537
DrugBank DB01413
ChemSpider 4586395 YesY
UNII 807PW4VQE3 YesY
KEGG D02376 YesY
ChEBI CHEBI:478164 YesY
ChEMBL CHEMBL186 YesY
Chemical data
Formula C19H24N6O5S2 
Mol. mass 480.56 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

Cefepime (INN) (pronounced /ˈsɛfɨpiːm/, /ˈkɛfɨpiːm/) is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime hydrochloride was first marketed in 1994 and is currently marketed under various trade names including Neopime(Neomed)Maxipime, Maxcef, Cepimax, Cepimex, and Axepim. A 2007 meta-analysis suggested that when data of trials were combined, mortality was increased in patients treated with cefepime compared with other β-lactam antibiotics.[1] In response, the U.S. Food and Drug Administration performed their own meta-analysis which found that there was no mortality difference.[2]

Contents

Clinical use

Cefepime is usually reserved to treat moderate-severe nosocomial pneumonia, infections caused by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.[3] The use of cefepime might become less common, since it has been associated to an increase mortality when used for different types of infections. <-- not true since 2009 - http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm167254.htm fix pls

Cefepime has good activity against important pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, and multiple drug resistant Streptococcus pneumoniae. A particular strength is its activity against Enterobacteriaceae. Whereas other cephalosporins are degraded by many plasmid- and chromosome-mediated beta-lactamases, cefepime is stable and is a front line agent when infection with Enterobacteriaceae is known or suspected.

Chemistry

The combination of the syn-configuration of the methoxyimino moiety and the aminothiazolyl moiety confers extra stability to β-lactamase enzymes produced by many bacteria. The N-methylpyrrolidine moiety increases penetration into Gram-negative bacteria. These factors increases the activity of cefepime against otherwise resistant organisms including Pseudomonas aeruginosa and Staphylococcus aureus.

References

  1. ^ Yahav D, Paul M, Fraser A, Sarid N, Leibovici L (2007). "Efficacy and safety of cefepime: a systematic review and meta-analysis". Lancet Infect Dis 7 (5): 338–48. doi:10.1016/S1473-3099(07)70109-3. PMID 17448937. 
  2. ^ "Information for Healthcare Professionals: Cefepime (marketed as Maxipime)". http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm167254.htm. Retrieved 2009-08-02. 
  3. ^ Chapman TM, Perry CM (2003). "Cefepime: a review of its use in the management of hospitalized patients with pneumonia". Am J Respir Med 2 (1): 75–107. PMID 14720024. 

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • Céfépime — Général No CAS …   Wikipédia en Français

  • Cefepime — o Cefepima; antibiótico del grupo de las cefalosporinas, de 4ª generación de aparición a mediados de la década de los 90. Resistente a betalactamasas. De utilización preferentemente intrahospitalaria en infecciones nosocomiales, de vías… …   Enciclopedia Universal

  • cefepime hydrochloride — the hydrochloride salt of cefepime, used in treatment of infections of the skin and soft tissues and of the respiratory and urinary tracts; administered intramuscularly or intravenously …   Medical dictionary

  • cefepime — noun A cephalosporin antibiotic …   Wiktionary

  • cefepime — cef·e·pime (sefґə pēm) a semisynthetic fourth generation cephalosporin, having greater resistance to β lactamases than do the third generation cephalosporins …   Medical dictionary

  • cefepime — A drug used to treat infection. It belongs to the family of drugs called cephalosporin antibiotics …   English dictionary of cancer terms

  • Beta-lactamase — Beta lactamases are enzymes (EC number|3.5.2.6) produced by some bacteria and are responsible for their resistance to beta lactam antibiotics like penicillins, cephalosporins, cephamycins, ertapenems and carbapenems. These antibiotics have a… …   Wikipedia

  • Cephalosporin — See also: Discovery and development of cephalosporins Core structure of the cephalosporins …   Wikipedia

  • Community-acquired pneumonia — (CAP) is a term used to describe one of several diseases in which individuals who have not recently been hospitalized develop an infection of the lungs (pneumonia). CAP is a common illness and can affect people of all ages. CAP often causes… …   Wikipedia

  • Cefquinome — Systematic (IUPAC) name 1 [[(6R,7R) 7 [[(2Z) (2 Amino 4 thiazolyl) (methoxyimino)acetyl]amino] 2 carboxy 8 oxo 5 thia 1 azabicyclo[4.2.0 oct 2 en 3 yl]methyl] 5,6,7,8 tetrahydroquinolinium inner salt …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”